von Niederhäusern Belinda, Orleth Annette, Schädelin Sabine, Rawi Nawal, Velkopolszky Martin, Becherer Claudia, Benkert Pascal, Satalkar Priya, Briel Matthias, Pauli-Magnus Christiane
Clinical Trial Unit, Department of Clinical Research, University Hospital Basel, Basel, Switzerland.
Department of Medicine, Biomedicine and Clinical Research, Neurology, University Hospital Basel, Basel, Switzerland.
BMC Med Res Methodol. 2017 Feb 14;17(1):26. doi: 10.1186/s12874-017-0308-6.
In spite of efforts to employ risk-based strategies to increase monitoring efficiency in the academic setting, empirical evidence on their effectiveness remains sparse. This mixed-methods study aimed to evaluate the risk-based on-site monitoring approach currently followed at our academic institution.
We selected all studies monitored by the Clinical Trial Unit (CTU) according to Risk ADApted MONitoring (ADAMON) at the University Hospital Basel, Switzerland, between 01.01.2012 and 31.12.2014. We extracted study characteristics and monitoring information from the CTU Enterprise Resource Management system and from monitoring reports of all selected studies. We summarized the data descriptively. Additionally, we conducted semi-structured interviews with the three current CTU monitors.
During the observation period, a total of 214 monitoring visits were conducted in 43 studies resulting in 2961 documented monitoring findings. Our risk-based approach predominantly identified administrative (46.2%) and patient right findings (49.1%). We identified observational study design, high ADAMON risk category, industry sponsorship, the presence of an electronic database, experienced site staff, and inclusion of vulnerable study population to be factors associated with lower numbers of findings. The monitors understand the positive aspects of a risk-based approach but fear missing systematic errors due to the low frequency of visits.
We show that the factors mostly increasing the risk for on-site monitoring findings are underrepresented in the current risk analysis scheme. Our risk-based on-site approach should further be complemented by centralized data checks, allowing monitors to transform their role towards partners for overall trial quality, and success.
尽管已努力采用基于风险的策略来提高学术环境中的监测效率,但关于其有效性的实证证据仍然稀少。这项混合方法研究旨在评估我们学术机构目前采用的基于风险的现场监测方法。
我们选择了2012年1月1日至2014年12月31日期间瑞士巴塞尔大学医院临床试验单位(CTU)根据风险适应性监测(ADAMON)监测的所有研究。我们从CTU企业资源管理系统和所有选定研究的监测报告中提取了研究特征和监测信息。我们对数据进行了描述性总结。此外,我们对CTU目前的三名监测人员进行了半结构化访谈。
在观察期内,对43项研究共进行了214次监测访问,产生了2961条记录在案的监测结果。我们基于风险的方法主要识别出行政方面(46.2%)和患者权利方面的结果(49.1%)。我们确定观察性研究设计、高ADAMON风险类别、行业赞助、存在电子数据库、经验丰富的研究点工作人员以及纳入脆弱研究人群是与较少结果数量相关的因素。监测人员理解基于风险方法的积极方面,但担心由于访问频率低而遗漏系统性错误。
我们表明,目前的风险分析方案中,最增加现场监测结果风险的因素未得到充分体现。我们基于风险的现场方法应进一步辅以集中数据检查,使监测人员能够将其角色转变为致力于整体试验质量和成功的合作伙伴。